Albireo Pharma Depreciation & Amortization 2011-2026 | ALBO

Annual Depreciation & Amortization Albireo Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
274 K	192 K	127 K	45 K	35 K	14 K	15 K	603 K	641 K	725 K	938 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
938 K	14 K	328 K

Quarterly Depreciation & Amortization Albireo Pharma

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	322 K	198 K	114 K	-	167 K	75 K	37 K	-	119 K	77 K	39 K	-	89 K	50 K	11 K	-	33 K	22 K	53 K	-	23 K	13 K	5 K	-	11 K	7 K	4 K	30 K	211 K	164 K	-	102 K	462 K	310 K	102 K	156 K	484 K	326 K	156 K	167 K	555 K	382 K	167 K	194 K	732 K	502 K	194 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
732 K	4 K	172 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.55	-2.18 %	$ 1.06 B	Canada
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
ADMA Biologics ADMA	8 M	$ 15.66	-5.32 %	$ 3.73 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.82	-0.73 %	$ 4.47 M	China
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Apellis Pharmaceuticals APLS	1.56 M	$ 20.16	1.51 %	$ 2.54 B	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
ANI Pharmaceuticals ANIP	67.7 M	$ 75.5	-1.35 %	$ 1.46 B	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.48	-9.2 %	$ 378 M	Britain
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Corcept Therapeutics Incorporated CORT	1.15 M	$ 34.35	-3.75 %	$ 3.57 B	USA
Corbus Pharmaceuticals Holdings CRBP	641 K	$ 7.8	-7.36 %	$ 33.8 M	USA
CorMedix CRMD	70.8 K	$ 6.32	-11.24 %	$ 322 M	USA
AVEO Pharmaceuticals AVEO	67 K	-	-	$ 521 M	USA
Champions Oncology CSBR	1.6 M	$ 5.79	-3.58 %	$ 79.1 M	USA
Axsome Therapeutics AXSM	503 K	$ 160.44	-2.22 %	$ 7.98 B	USA
BridgeBio Pharma BBIO	5.43 M	$ 65.38	-1.74 %	$ 12.5 B	USA
Denali Therapeutics DNLI	7.8 M	$ 19.69	-3.34 %	$ 3.24 B	USA
Brainstorm Cell Therapeutics BCLI	240 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Edesa Biotech EDSA	186 K	$ 3.8	-10.9 %	$ 12.2 M	USA
Equillium EQ	126 K	$ 1.79	2.0 %	$ 62.2 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	79.6 M	$ 60.47	0.07 %	$ 11.6 B	USA
Eton Pharmaceuticals ETON	901 K	$ 17.04	-2.77 %	$ 437 M	USA